beta Casein Antibody (29D6) - BSA Free

Immunohistochemistry: beta Casein Antibody (29D6) [NBP3-26642] -

Immunohistochemistry: beta Casein Antibody (29D6) [NBP3-26642] - Image of beta Casein Antibody (29D6) diluted at 1:100 and staining in paraffin-embedded human colon cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.05% DAB.

Immunohistochemistry: beta Casein Antibody (29D6) [NBP3-26642] -

Immunohistochemistry: beta Casein Antibody (29D6) [NBP3-26642] - Image of beta Casein Antibody (29D6) diluted at 1:100 and staining in paraffin-embedded human colon cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.05% DAB.

Flow Cytometry: beta Casein Antibody (29D6) [NBP3-26642] -

Flow Cytometry: beta Casein Antibody (29D6) [NBP3-26642] - Overlay Peak curve showing HepG2 cells stained with beta Casein Antibody (29D6) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.